chenodeoxycholic acid has been researched along with epidermal growth factor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelini, A; Barone, M; Francavilla, A; Panella, C; Romanelli, D | 1 |
| Apicella, C; Barone, MV; Barretta, ML; Capasso, L; Nanayakkara, M; Paludetto, R; Pappacoda, S; Raimondi, F; Santoro, P | 1 |
| Andò, S; Barone, I; Bonofiglio, D; Catalano, S; Fuqua, SA; Gelsomino, L; Giordano, C; Panza, S; Rizza, P; Vizza, D | 1 |
3 other study(ies) available for chenodeoxycholic acid and epidermal growth factor
| Article | Year |
|---|---|
Studies in vitro on the influence of ursodeoxycholate sodium salt (UDC) on hepatocyte proliferation.
Topics: Animals; Bile Acids and Salts; Cell Division; Cell Survival; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Deoxycholic Acid; DNA; Epidermal Growth Factor; Insulin; Liver; Male; Rats; Rats, Inbred F344; Thymidine; Tritium; Ursodeoxycholic Acid | 1993 |
Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation.
Topics: Antibodies, Monoclonal; Bile Acids and Salts; Caco-2 Cells; Chenodeoxycholic Acid; Cholic Acid; Deoxycholic Acid; Dextrans; Electric Impedance; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Humans; Intestinal Mucosa; Kinetics; Membrane Proteins; Occludin; Organometallic Compounds; Organophosphorus Compounds; Permeability; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Tight Junctions | 2008 |
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chenodeoxycholic Acid; Chromatin Immunoprecipitation; Down-Regulation; Drug Resistance, Neoplasm; Electrophoretic Mobility Shift Assay; Epidermal Growth Factor; Female; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Mitogen-Activated Protein Kinase 3; NF-kappa B; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Tamoxifen | 2011 |